Capital expenditure · 2011–2025
Sinovac Biotech capital expenditure
$48.9M−49.0% · FY2025
Sinovac Biotech (SVA) reported $48.9M in capital expenditure for fiscal 2025, −49.0% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $48.9M | −49.0% | Open → |
| FY20242024-12-31 | $96.0M | −38.6% | Open → |
| FY20232023-12-31 | $156M | −50.2% | Open → |
| FY20222022-12-31 | $314M | −47.2% | Open → |
| FY20212021-12-31 | $594M | +366.1% | Open → |
| FY20202020-12-31 | $127M | +1,099.5% | Open → |
| FY20192019-12-31 | $10.6M | +89.3% | Open → |
| FY20182018-12-31 | $5.6M | −52.9% | Open → |
| FY20172017-12-31 | $11.9M | −5.8% | Open → |
| FY20162016-12-31 | $12.7M | +138.8% | Open → |
| FY20152015-12-31 | $5.3M | −51.4% | Open → |
| FY20142014-12-31 | $10.9M | +112.6% | Open → |
| FY20132013-12-31 | $5.1M | −68.2% | Open → |
| FY20122012-12-31 | $16.2M | +4.5% | Open → |
| FY20112011-12-31 | $15.5M | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +8.6%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Sinovac Biotech capital expenditure |url=https://companiesranked.com/en/company/sinovac-biotech/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Sinovac Biotech capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/sinovac-biotech/capital-expenditureBibTeX
@misc{companiesranked-en-company-sinovac-biotech-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Sinovac Biotech capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/sinovac-biotech/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 20-F · 0001193125-26-258534 · June 5, 2026
{{cite web |title=Sinovac Biotech capital expenditure — 20-F (0001193125-26-258534) |url=https://www.sec.gov/Archives/edgar/data/1084201/000119312526258534/sva-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-06-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.